Bmsi.co.in

PRINCETON, N.J., Oct 28, 2015 (BUSINESS WIRE) — Bristol-Myers Squibb Company BMY, +0.60% today announced that the U.S. Food and Drug Administration (FDA) has approved Yervoy (ipilimumab) 10 mg/kg for the adjuvant treatment of patients with cutaneous...

Giles Platford, president, Emerging Markets, Takeda (right) and Dr. Kibachio Joseph Mwangi (left), Head: Division of Non-Communicable Diseases, Ministry of Health, at the launch of Takeda’s bold, new Access to Medicines strategy Announcement made on...

By John Murphy It’s ironic that today’s life-saving medicines often resemble modern miracles while the biopharmaceutical companies that create them draw the ire of activist groups. This drama is playing out again in the context of the Trans-Pacific...

(CBS News) – More than 29 million Americans live with diabetes, and for some six million of them, insulin is a life or death medication. Between 2002 and 2013, the price of insulin more than tripled, to more than $700 per patient. A federal lawsuit...

Over the last three years, pharmaceutical companies have mounted a public relations blitz to tout new cures for the hepatitis C virus and persuade insurers, including government programs such as Medicare and Medicaid, to cover the costs. That isn’t an...